Growth will be where structural reforms gain traction: Watch EM
Read More
A close look at China Cord Blood, one of the growth stocks that form 10-20% of our portfolio
A tutorial: elaborating on our focus on free cash flow and dividends
Exploration of themes to explain our macro beliefs and fundamental investment thesis guiding our portfolio construction process